# Efficacy of Bifeprunox in Patients With Schizophrenia

> **NCT00704509** · PHASE3 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 346 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Bifeprunox
- **DRUG:** Placebo
- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT00704509
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2009-08
- **Final completion:** 2009-11
- **Target enrollment:** 346 (ACTUAL)
- **Why stopped:** Interim analysis showed inadequate efficacy of bifeprunox
- **Last updated:** 2010-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704509, "Efficacy of Bifeprunox in Patients With Schizophrenia". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT00704509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*